What is it about?

Severe asthma is a very serious condition with a large impact on the life of patients. Researchers from different countries in Europe have systematically collected data from severe asthma patients in registries. This study was set up to provide an overview of what data is currently collected in those registries and to show what differences exist between patients with severe asthma in different countries in Europe. We found that many differences exist between the characteristics of patients in different European countries. We also found that treatment of patients with severe asthma is different across European countries.

Featured Image

Why is it important?

Much is still unknown about severe asthma and it seems to be a very complex disease. The current study can help to provide a view on what is considered severe asthma in different countries in Europe. This is important to provide new insights in what is necessary for doing research in a large scale registry across European countries and, in addition, to make sure that registries across Europe use the same standards and definitions.


This is article is the first paper (I hope of many) that has been published by the SHARP consortium. SHARP aims to answer a lot of important, yet still unanswered questions in severe asthma. I see this paper as a proof-of-principle that has shown that collaboration is not only feasible, but is already able to provide some very intersting insights in the way severe asthma is seen differently across Europe. Furthermore the current study provides a stepping-stone to enable future research within the SHARP consortium. This article provided me a great opportunity as a junior researcher to get involved in a large-scale international project and to work together with researchers all across Europe.

Job J.M.H. van Bragt
Amsterdam UMC, University of Amsterdam

Read the Original

This page is a summary of: Characteristics and treatment regimens across ERS SHARP severe asthma registries, European Respiratory Journal, October 2019, European Respiratory Society (ERS), DOI: 10.1183/13993003.01163-2019.
You can read the full text:




The following have contributed to this page